Published in N Engl J Med on March 30, 2006
Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev (2007) 6.38
Emergence and predominance of an H5N1 influenza variant in China. Proc Natl Acad Sci U S A (2006) 4.49
Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am J Pathol (2008) 2.36
Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLoS One (2008) 2.28
Pandemic influenza and pregnant women: summary of a meeting of experts. Am J Public Health (2009) 2.09
Indications that live poultry markets are a major source of human H5N1 influenza virus infection in China. J Virol (2011) 1.85
H5N1 influenza viruses: outbreaks and biological properties. Cell Res (2009) 1.72
H5N1 influenza viruses in Lao People's Democratic Republic. Emerg Infect Dis (2006) 1.64
The survey of H5N1 flu virus in wild birds in 14 Provinces of China from 2004 to 2007. PLoS One (2009) 1.21
Human influenza A virus (H5N1) detection by a novel multiplex PCR typing method. J Clin Microbiol (2007) 1.19
Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates. PLoS Pathog (2009) 1.18
Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaque. J Virol (2012) 1.05
Avian influenza virus, Streptococcus suis serotype 2, severe acute respiratory syndrome-coronavirus and beyond: molecular epidemiology, ecology and the situation in China. Philos Trans R Soc Lond B Biol Sci (2009) 1.04
Neuraminidase and hemagglutinin matching patterns of a highly pathogenic avian and two pandemic H1N1 influenza A viruses. PLoS One (2010) 1.02
The metabolism and transplacental transfer of oseltamivir in the ex vivo human model. Infect Dis Obstet Gynecol (2008) 1.02
Characteristics of human infection with avian influenza viruses and development of new antiviral agents. Acta Pharmacol Sin (2013) 0.94
Comprehensive analysis of pathogen-specific antibody response in vivo based on an antigen library displayed on surface of yeast. J Biol Chem (2011) 0.93
Polyvalent DNA vaccines expressing HA antigens of H5N1 influenza viruses with an optimized leader sequence elicit cross-protective antibody responses. PLoS One (2011) 0.92
Emerging and zoonotic infections in women. Infect Dis Clin North Am (2008) 0.89
Characterization of neuraminidases from the highly pathogenic avian H5N1 and 2009 pandemic H1N1 influenza A viruses. PLoS One (2010) 0.89
Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production. Influenza Other Respir Viruses (2009) 0.87
Use of ex vivo and in vitro cultures of the human respiratory tract to study the tropism and host responses of highly pathogenic avian influenza A (H5N1) and other influenza viruses. Virus Res (2013) 0.83
The antigenic property of the H5N1 avian influenza viruses isolated in central China. Virol J (2012) 0.81
The nucleoprotein and matrix protein segments of H5N1 influenza viruses are responsible for dominance in embryonated eggs. J Gen Virol (2011) 0.78
Comparative virus replication and host innate responses in human cells infected with three prevalent clades (2.3.4, 2.3.2, and 7) of highly pathogenic avian influenza H5N1 viruses. J Virol (2013) 0.77
A replicating modified vaccinia tiantan strain expressing an avian-derived influenza H5N1 hemagglutinin induce broadly neutralizing antibodies and cross-clade protective immunity in mice. PLoS One (2013) 0.76
Highly pathogenic avian influenza H5N1 virus could partly be evacuated by pregnant BALB/c mouse during abortion or preterm delivery. Virol J (2011) 0.75
Reliability of pseudotyped influenza viral particles in neutralizing antibody detection. PLoS One (2014) 0.75
Intranasal Immunization of Mice to Avoid Interference of Maternal Antibody against H5N1 Infection. PLoS One (2016) 0.75
Avian influenza A (H5N1) infection in a patient in China, 2006. Influenza Other Respir Viruses (2009) 0.75
Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med (2013) 24.88
Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis (2012) 8.02
Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med (2013) 7.52
Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet (2013) 6.10
Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis (2007) 5.21
Nosocomial transmission of human granulocytic anaplasmosis in China. JAMA (2008) 5.01
Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet (2008) 4.17
An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J (2010) 3.90
Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet (2013) 3.77
Human Streptococcus suis outbreak, Sichuan, China. Emerg Infect Dis (2006) 3.65
The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature (2013) 3.60
Biological features of novel avian influenza A (H7N9) virus. Nature (2013) 3.24
Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2. PLoS Med (2006) 2.99
Monitoring avian influenza A(H7N9) virus through national influenza-like illness surveillance, China. Emerg Infect Dis (2013) 2.61
Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact. Clin Infect Dis (2011) 2.59
Risk factors for human illness with avian influenza A (H5N1) virus infection in China. J Infect Dis (2009) 2.50
Severe fever with thrombocytopenia syndrome virus among domesticated animals, China. Emerg Infect Dis (2013) 2.35
Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses. Science (2013) 2.34
Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLoS One (2008) 2.28
Early diagnosis of novel SFTS bunyavirus infection by quantitative real-time RT-PCR assay. J Clin Virol (2011) 2.19
Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice. Vaccine (2010) 1.92
Sequential reassortments underlie diverse influenza H7N9 genotypes in China. Cell Host Microbe (2013) 1.89
Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. Clin Infect Dis (2011) 1.87
Indications that live poultry markets are a major source of human H5N1 influenza virus infection in China. J Virol (2011) 1.85
High genetic compatibility and increased pathogenicity of reassortants derived from avian H9N2 and pandemic H1N1/2009 influenza viruses. Proc Natl Acad Sci U S A (2011) 1.85
The first confirmed human case of avian influenza A (H5N1) in Mainland China. Lancet (2006) 1.79
Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4. Nat Genet (2012) 1.78
H5N1 influenza viruses: outbreaks and biological properties. Cell Res (2009) 1.72
Human influenza A (H5N1) cases, urban areas of People's Republic of China, 2005-2006. Emerg Infect Dis (2007) 1.71
Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model. Proc Natl Acad Sci U S A (2012) 1.71
Influenza-associated mortality in temperate and subtropical Chinese cities, 2003-2008. Bull World Health Organ (2012) 1.69
Outbreak of acute respiratory disease in China caused by B2 species of adenovirus type 11. J Clin Microbiol (2008) 1.67
Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China. Emerg Infect Dis (2004) 1.65
Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans. Vaccine (2010) 1.65
Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet (2012) 1.64
Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndrome. J Infect Dis (2012) 1.62
Serologic study for influenza A (H7N9) among high-risk groups in China. N Engl J Med (2013) 1.59
The seroprevalence of pandemic influenza H1N1 (2009) virus in China. PLoS One (2011) 1.54
Novel bunyavirus in domestic and captive farmed animals, Minnesota, USA. Emerg Infect Dis (2013) 1.53
Open source clinical science for emerging infections. Lancet Infect Dis (2014) 1.47
Inhibition of autophagy ameliorates acute lung injury caused by avian influenza A H5N1 infection. Sci Signal (2012) 1.45
Seasonal influenza vaccine supply and target vaccinated population in China, 2004-2009. Vaccine (2010) 1.43
Genomic analyses of recombinant adenovirus type 11a in China. J Clin Microbiol (2009) 1.41
Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1. Clin Infect Dis (2014) 1.40
An airborne transmissible avian influenza H5 hemagglutinin seen at the atomic level. Science (2013) 1.39
Key molecular factors in hemagglutinin and PB2 contribute to efficient transmission of the 2009 H1N1 pandemic influenza virus. J Virol (2012) 1.37
Knowledge, attitudes and practices (KAP) relating to avian influenza in urban and rural areas of China. BMC Infect Dis (2010) 1.36
Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses. PLoS One (2009) 1.33
Novel avian influenza A(H7N9) virus in tree sparrow, Shanghai, China, 2013. Emerg Infect Dis (2014) 1.30
Poultry market closures and human infection with influenza A(H7N9) virus, China, 2013-14. Emerg Infect Dis (2014) 1.29
One family cluster of avian influenza A(H7N9) virus infection in Shandong, China. BMC Infect Dis (2014) 1.26
Human influenza A virus (H5N1) detection by a novel multiplex PCR typing method. J Clin Microbiol (2007) 1.19
Challenges and needs for China to eliminate rabies. Infect Dis Poverty (2013) 1.17
Suppression of the interferon and NF-κB responses by severe fever with thrombocytopenia syndrome virus. J Virol (2012) 1.17
Human exposure to live poultry and psychological and behavioral responses to influenza A(H7N9), China. Emerg Infect Dis (2014) 1.17
Knowledge, attitudes and practices (KAP) related to the pandemic (H1N1) 2009 among Chinese general population: a telephone survey. BMC Infect Dis (2011) 1.15
Modification of nonstructural protein 1 of influenza A virus by SUMO1. J Virol (2010) 1.13
Travel patterns in China. PLoS One (2011) 1.12
Mapping of H3N2 influenza antigenic evolution in China reveals a strategy for vaccine strain recommendation. Nat Commun (2012) 1.12
Critical epitopes in the nucleocapsid protein of SFTS virus recognized by a panel of SFTS patients derived human monoclonal antibodies. PLoS One (2012) 1.07
A systematic molecular pathology study of a laboratory confirmed H5N1 human case. PLoS One (2010) 1.07
Potent inhibition of human influenza H5N1 virus by oligonucleotides derived by SELEX. Biochem Biophys Res Commun (2007) 1.07
Malaria imported from Ghana by returning gold miners, China, 2013. Emerg Infect Dis (2015) 1.05
Genetic analysis of chikungunya viruses imported to mainland China in 2008. Virol J (2010) 1.05
Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1): role of the host immune response in pathogenesis. Am J Pathol (2013) 1.04
The neuraminidase inhibitor oseltamivir is effective against A/Anhui/1/2013 (H7N9) influenza virus in a mouse model of acute respiratory distress syndrome. J Infect Dis (2013) 1.03
Neuraminidase and hemagglutinin matching patterns of a highly pathogenic avian and two pandemic H1N1 influenza A viruses. PLoS One (2010) 1.02
Generation of recombinant vaccinia viruses expressing Puumala virus proteins and use in isolating cytotoxic T cells specific for Puumala virus. Virus Res (2002) 1.01
Differential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 viruses. J Virol (2010) 1.01
Mutations in polymerase genes enhanced the virulence of 2009 pandemic H1N1 influenza virus in mice. PLoS One (2012) 1.00
Incubation period for human cases of avian influenza A (H5N1) infection, China. Emerg Infect Dis (2008) 1.00
Structure of severe fever with thrombocytopenia syndrome virus nucleocapsid protein in complex with suramin reveals therapeutic potential. J Virol (2013) 0.99
Seasonal influenza vaccine policies, recommendations and use in the World Health Organization's Western Pacific Region. Western Pac Surveill Response J (2013) 0.99
Genetic score of multiple risk-associated single nucleotide polymorphisms is a marker for genetic susceptibility to bladder cancer. Genes Chromosomes Cancer (2013) 0.98
Pneumonia incidence and mortality in Mainland China: systematic review of Chinese and English literature, 1985-2008. PLoS One (2010) 0.97
Geographical analysis of the distribution and spread of human rabies in china from 2005 to 2011. PLoS One (2013) 0.97
Correlation of influenza virus excess mortality with antigenic variation: application to rapid estimation of influenza mortality burden. PLoS Comput Biol (2010) 0.97
Avian influenza A(H5N1) viruses can directly infect and replicate in human gut tissues. J Infect Dis (2010) 0.96
Functional annotation of risk loci identified through genome-wide association studies for prostate cancer. Prostate (2010) 0.95
Inactivation of the novel avian influenza A (H7N9) virus under physical conditions or chemical agents treatment. Virol J (2013) 0.94